Congo vs Sierra Leone: HIV/AIDS deaths averted by antiretroviral therapy
Congo
4,099 deaths
in 2024
Sierra Leone
4,079 deaths
in 2024
Congo rank
43rd
Sierra Leone rank
44th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Congo
- Sierra Leone
How they compare
Congo currently reports 4,099 deaths against 4,079 deaths in Sierra Leone, a difference of 20 deaths.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Sierra Leone ahead.
Congo ranks 43rd and Sierra Leone ranks 44th of 157 countries.
Across the 4 decades both report, Congo averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Congo | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 655.59 deaths | 163.18 deaths | 492.41 deaths | Congo |
| 2010s | 2,300 deaths | 1,770 deaths | 530.16 deaths | Congo |
| 2020s | 3,230 deaths | 3,547 deaths | 317.51 deaths | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Congo or Sierra Leone?
- Congo, at 4,099 deaths against 4,079 deaths in Sierra Leone as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Congo and Sierra Leone?
- 20 deaths, with Congo ahead.
- How many years of comparable data are there for Congo and Sierra Leone?
- 35 years are reported by both, from 1990 to 2024.
- How do Congo and Sierra Leone rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Congo ranks 43rd and Sierra Leone ranks 44th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.